2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




FDA Proposes Expedited Access Program for Medical Devices That Address Unmet Medical Needs

April 22, 2014—The US Food and Drug Administration (FDA) announced a proposed new program to provide earlier access to medical devices that are intended to treat or diag…

Study Evaluates Secondary Procedures After Implantation With Medtronic’s Talent and Valiant TEVAR Grafts

April 21, 2014—In the Journal of Vascular and Interventional Radiology (JVIR), Alan H. Matsumoto, MD, et al published findings on secondary procedures followin…

Long-Term Data Presented for Medtronic’s Endurant AAA Stent Graft

April 18, 2014—Medtronic, Inc. (Santa Rosa, CA) announced that new clinical data supporting the company’s Endurant abdominal aortic aneurysm (AAA) stent graft syst…

TriVascular Sets Price and Commences IPO

April 15, 2014—TriVascular Technologies, Inc. (Santa Rosa, CA) announced a price of $12 per share in its initial public offering of 6,500,000 shares of its common stock.…

Click here for more News coverage

Current Supplements

Sponsored by Boston Scientific Corporation

Master the Cross

Leading endovascular experts describe the many techniques and tools required to conquer the challenges of CTOs in PVD.

Sponsored by Medtronic, Inc.

Refining Strategies for the SFA

A panel of experts discusses the promise of drug-eluting balloons and other techniques for treating SFA and popliteal lesions.

Featured Center



Featured Video

EVAR in a Patient With Severe Aortoiliac Disease




Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media